The present invention relates to novel pyrido[2,3-b]pyrazine derivatives of formula (I) and to the use of such compounds in which the inhibition, regulation and/or modulation of signal transduction by ATP consuming proteins like kinases plays a role, particularly to inhibitors of TGF-beta receptor kinases, and to the use of such compounds for the treatment of kinase-induced diseases, in particular for the treatment of tumors.
本发明涉及公式(I)的新型
吡啶[2,3-b]
吡嗪衍
生物,以及在其中
ATP消耗蛋白质如激酶的
信号转导的抑制、调节和/或调制中发挥作用的化合物的使用,特别是TGF-beta受体激酶的
抑制剂,并且本发明涉及这些化合物用于治疗激酶诱导疾病,特别是用于治疗肿瘤。